StockData

Aurora Cannabis vs Canopy Growth

ACB and CGC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ACB and CGC compare

Aurora Cannabis grew revenue faster over the last twelve months (11.0% versus 10.7% for Canopy Growth).

Aurora Cannabis scores higher on the StockData Score (6 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricACBCGC
Size and price
Share price$4.94$0.561
Change, 1 year9.1%−52.8%
Change, 5 years−93.0%−99.5%
Beta (5Y)1.311.89
Employees–1,128
StockData Score
Total score6 (better)3
Valuation score00
Growth score11
Performance score01 (better)
Health score5 (better)1
Dividend score00
Growth
Revenue growth (TTM)11.0% (better)10.7%
Revenue growth, 5Y average5.5% (better)−12.2%
EPS growth (TTM)−5450%–
Profitability
Gross margin42.6% (better)24.4%
Operating margin–−54.2%
Net margin–−87.0%
FCF margin–−25.8%
Financial health
Debt / equity0.00–
Interest coverage–−3.7×
Current ratio5.94 (better)2.82
Piotroski F-score–5
Ownership
Held by institutions8.9%6.9%
Held by insiders0.00%1.0%
Insider net buying, 12 months–−$393K

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.